Researchers at the QIMR Berghofer Medical Research Institute are undertaking ground-breaking research to help identify genetic factors influencing risk of developing Parkinson’s disease. This research, named the Australian Parkinson’s Genetics Study (APGS), will contribute towards the largest study of Parkinson’s genetics ever undertaken, the Global Parkinson’s Genetics Program (GP2).
The APGS aims to crack the genetic code of Parkinson’s by helping to identify the hundreds of genetic variants that influence a person’s risk of developing the condition and its various symptoms. Understanding how genes are implicated in the disease process can provide insights and revolutionise future research into the causes, treatment, and prevention of the illness and its progression, and enable the development of new, and more effective, and more personalised treatments for the disease.
The APGS research team aims to recruit 10,000 Australian residents (male or female) who have been diagnosed with, and medically treated for, Parkinson’s disease. Study participants will be showing generosity and solidarity in supporting others living with this disease and will be making a genuine contribution to the future diagnosis, management, and treatment of the condition. Watch the below recording of the March Research Forum to learn more about this important new research study.